Vizora日本語

MedinetMEDINET Co., Ltd.2370東証グロースサービス業FY ending Sep 2025, non-consolidated, J-GAAP

Medinet FY ending Sep 2019 results

About 99% of Medinet's sales come from Contracted Cell Manufacturing Business, with Cellular and tissue-based product business making up much of the rest.

It lost about ¥95 for every ¥100 of sales at the operating level.

Where the money goes

Where ¥100 of sales goes

For every ¥100 Medinet sells, how much goes where, and how much is kept.

FY ending Sep 2019
Cost of sales
¥62
SG&A
¥133
Operating loss
¥95
Net loss
¥75

Margin funnel (derived from reported values)Gross margin 37.8% → Operating margin -95.2% → Net margin -75.1%

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Sep 2019

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (3)

  • EDINET (FSA Japan)

    有価証券報告書－第28期(2022/10/01－2023/09/30)

    ID S100SI7J2023-12-21Open

  • EDINET (FSA Japan)

    有価証券報告書－第26期(令和2年10月1日－令和3年9月30日)

    ID S100N2N22021-12-16Open

  • EDINET (FSA Japan)

    有価証券報告書－第25期(令和1年10月1日－令和2年9月30日)

    ID S100KDPI2020-12-17Open

Extracted from XBRL: 36 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image